ACRV
ACRIVON THERAPEUTICS INC

849
Loading...
Loading...
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
78

Frequently Asked Questions

What is Market Cap of Acrivon Therapeutics Inc?
What is the 52-week high for Acrivon Therapeutics Inc?
What is the 52-week low for Acrivon Therapeutics Inc?
What is Acrivon Therapeutics Inc stock price today?
What was Acrivon Therapeutics Inc stock price yesterday?
What is the PE ratio of Acrivon Therapeutics Inc?
What is the Price-to-Book ratio of Acrivon Therapeutics Inc?
What is the 50-day moving average of Acrivon Therapeutics Inc?
How many employess does Acrivon Therapeutics Inc has?

Latest ACRV News

View

Advertisement. Remove ads.

Advertisement. Remove ads.